Availability of menopausal hormone therapy products worldwide

The menopause transition can have a significant impact on many women, with more than 75% experiencing menopausal symptoms, and a quarter describing severe symptoms. Symptoms on average last 7 years and a third of women experience long-term symptoms. Menopausal hormone therapy (MHT), compared with placebo, has consistently shown improvements in menopausal symptoms and overall quality of life. Furthermore, MHT has a significant protective effect against osteoporosis and cardiovascular disease in women initiating MHT under the age of 60 [1,2].
Source: Maturitas - Category: Primary Care Authors: Source Type: research